Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06584240
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-02
Brief Title:
A Phase IbII Clinical Study to Evaluate the Safety and Efficacy of JHM03 in Adult Patients with Upper Limb Spasticity
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase IbII Clinical Study to Evaluate the Safety and Efficacy of Recombinant Botulinum Toxin Type a JHM03 in Adult Patients with Upper Limb Spasticity
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a phase IbII clinical study to evaluate the safety and efficacy of recombinant botulinum toxin type AJHM03in adult patients with upper limb spasticity The purpose of this study was to observe efficacy and safety of JHM03 compared with placebo in adult patients with upper limb spasticity
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None